This bill provides emergency funding to federally qualified health centers in Maine to help them expand retail pharmacy services in underserved areas. The legislation allocates $699,150 in fiscal year 2026, with $44,250 given to each health center plus an additional $8,850 for each additional site they operate. The funding is intended to support infrastructure that allows these centers to offer prescription drugs more directly to patients when retail pharmacy options are limited. It addresses concerns about reduced pharmacy access in rural areas and conflicting requirements from drug manufacturers under the federal 340B program. The bill takes effect immediately as an emergency measure to preserve public health and safety.
This bill ensures continued funding for Maine's children's residential care facilities by making newly appropriated funds nonlapsing - meaning unspent money carries over to future fiscal years instead of expiring. It directly affects facilities that provide residential care for children and receive reimbursement through MaineCare (the state's Medicaid program), which face potential bed reductions or closures due to funding gaps. The bill removes a requirement for an emergency rate adjustment process for these facilities, streamlining how they receive funding. Key provisions focus on stabilizing financial support to maintain access to critical care services for vulnerable children.
This bill requires the Maine Department of Health and Human Services to amend its rules so that hospitals participating in MaineCare receive at least 75% of the amount they report for costs within 90 days of submitting their cost reports. It directly affects hospitals that submit cost reports for reimbursement under MaineCare, the state's Medicaid program. The change mandates this timeline and reimbursement rate through updates to the MaineCare Benefits Manual (Chapter 101, Chapter III, Section 45) and must be implemented using existing department resources without new state funding.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
This Maine bill amends state labor law to prohibit employers from requiring or enforcing noncompete agreements with licensed health care practitioners. The legislation defines a "health care practitioner" as any individual qualified under state law to provide medical services, thereby extending existing protections for low-wage workers and certain veterinarians to this broader group. Additionally, the bill removes a specific exemption that previously allowed noncompete agreements between employers and allopathic or osteopathic physicians to take effect immediately, subjecting them instead to standard waiting periods based on tenure or signing date.
This bill expands the list of vaccines available through Maine's Universal Immunization Program by requiring the state board to include vaccines recommended by the Northeast Public Health Collaborative alongside those recommended by federal health authorities. It allows the program to request state funding to cover costs for children who qualify for vaccines under the federal Vaccines for Children Program when federal funds are insufficient, provided the vaccines align with state or regional health guidelines. Additionally, the bill grants licensed pharmacists immunity from negligence lawsuits if they administer vaccines that follow state or regional recommendations, even when those vaccines fall outside federal guidelines. These changes directly affect Maine's vaccine distribution system, healthcare providers, and families seeking immunizations for their children.
This bill requires health insurance plans in Maine to cover blood testing for perfluoroalkyl and polyfluoroalkyl substances (PFAS) when a healthcare provider deems it medically necessary based on guidelines from the National Academies of Sciences, Engineering, and Medicine. It prohibits insurers from charging deductibles, copays, or coinsurance for these tests. The requirement applies to all health insurance plans issued or renewed in Maine on or after January 1, 2026. The bill states this coverage does not expand the state's essential health benefits under federal law, as it aligns with existing coverage for outpatient lab services.
This resolve authorizes the final adoption of specific regulatory provisions concerning the prescriptive authorities and collaborative relationships for naturopathic doctors in Maine. The Department of Professional and Financial Regulation submitted these rules to the legislature after the standard filing deadline, which required a special legislative action to approve them. By passing this measure, the state legislature grants the necessary approval for these professional practice standards to take effect immediately.
This bill expands vaccine access in Maine by allowing licensed pharmacists to prescribe, dispense, and administer FDA-approved vaccines without requiring a doctor's prescription for eligible patients. It requires health insurance plans and the MaineCare program to cover all vaccines without deductibles, copayments, or other out-of-pocket costs, including coverage for off-label vaccine use. Pharmacists can administer influenza vaccines to people aged 3 and older, and other CDC-recommended vaccines to adults 18 and older, with additional authority for COVID-19 vaccines to those aged 3 and older. The legislation also clarifies legal definitions for off-label use and medically accepted indications to support these expanded prescribing and administration powers.
This bill amends Maine's optometry practice laws to clarify the scope of services optometrists can provide. It explicitly permits optometrists to prescribe hydrocodone combination products and other controlled substances (such as schedule III-V drugs) for eye conditions, while listing specific procedures excluded from optometry practice (e.g., corneal transplants, retinal surgery, and surgeries requiring general anesthesia). The bill also requires optometrists to meet board-established credentialing standards before performing any ophthalmic surgery or laser procedures. These changes directly affect Maine optometrists by defining their prescribing authority and procedural boundaries.
